The latest price target for Acadia Healthcare Co (NASDAQ:ACHC) was reported by RBC Capital on November 18, 2024. The analyst firm set a price target for $64.00 expecting ACHC to rise to within 12 months (a possible 67.54% upside). 29 analyst firms have reported ratings in the last year.

The latest analyst rating for Acadia Healthcare Co (NASDAQ:ACHC) was provided by RBC Capital, and Acadia Healthcare Co maintained their outperform rating.

The last upgrade for Acadia Healthcare Co Inc happened on April 25, 2024 when Deutsche Bank raised their price target to $70. Deutsche Bank previously had a sell for Acadia Healthcare Co Inc.

The last downgrade for Acadia Healthcare Co Inc happened on April 20, 2023 when Deutsche Bank changed their price target from $75 to $63 for Acadia Healthcare Co Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acadia Healthcare Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acadia Healthcare Co was filed on November 18, 2024 so you should expect the next rating to be made available sometime around November 18, 2025.

While ratings are subjective and will change, the latest Acadia Healthcare Co (ACHC) rating was a maintained with a price target of $94.00 to $64.00. The current price Acadia Healthcare Co (ACHC) is trading at is $38.20, which is out of the analyst’s predicted range.